Sign up
Pharma Capital

OptiBiotix Health creating multiple channel opportunities across its portfolio

Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) caught up with Proactive's Andrew Scott to discuss their two recent announcements - with Bened Biomedical and a US pharmaceutical company.

''There's a lot of things going on, a lot of deals currently in place with a lot of deal flow and plans for the future''.

''We're creating multiple channel opportunities, both in terms of online and across multiple territories ... and not just for supplements and ingredients but also pharmaceuticals''.


View full OPTI profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.